Ms. Cheung, Chief Business Officer at Moonwalk Biosciences, has led biotech corporate & business development, pharma transactions, corporate strategy, fundraising, and operations for 20+ years. She was most recently SVP Business Development & Corporate Strategy at Lyell Immunopharma, where she oversaw the company’s BD/licensing, acquisition, and divestiture activities, and helped take the company public. Before that, Ms. Cheung was a VP at Mindstrong Health, leading operations, communications and marketing/policy. She was a founding employee and Head of Business Development at GRAIL, having led the operational spin-out from Illumina. She spent several years in BD at Illumina advancing the company’s clinical product strategies, having been recruited from Genomic Health (now Exact Sciences) where she focused on growing the company’s OncoType Dx™ product portfolio and global commercial footprint. Ms. Cheung earned a B.S. in Biological Sciences and an M.S. in Management Science & Engineering, both from Stanford University, where she was also a Mayfield Fund Fellow.